HYMN (bladder cancer)

The HYMN trial was a Phase III trial evaluating hyperthermic mitomycin in patients with a recurrence of bladder cancer after BCG therapy. The trial recruited patients across 10 UK sites and is now completed.


We hope to publish the results of HYMN in the very near future and will post an update here.